These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


211 related items for PubMed ID: 19520522

  • 1. Does varicella-zoster virus infection of the peripheral ganglia cause Chronic Fatigue Syndrome?
    Shapiro JS.
    Med Hypotheses; 2009 Nov; 73(5):728-34. PubMed ID: 19520522
    [Abstract] [Full Text] [Related]

  • 2. [Reactivation of herpes zoster infection by varicella-zoster virus].
    Cvjetković D, Jovanović J, Hrnjaković-Cvjetković I, Brkić S, Bogdanović M.
    Med Pregl; 1999 Nov; 52(3-5):125-8. PubMed ID: 10518396
    [Abstract] [Full Text] [Related]

  • 3. Varicella-zoster virus: overview and clinical manifestations.
    Arvin AM.
    Semin Dermatol; 1996 Jun; 15(2 Suppl 1):4-7. PubMed ID: 8840410
    [Abstract] [Full Text] [Related]

  • 4. Molecular studies of Varicella zoster virus.
    Quinlivan M, Breuer J.
    Rev Med Virol; 2006 Jun; 16(4):225-50. PubMed ID: 16791838
    [Abstract] [Full Text] [Related]

  • 5. [Prevention and therapy of herpesvirus infections].
    Abb J.
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
    [Abstract] [Full Text] [Related]

  • 6. The effect of vaccination on the epidemiology of varicella zoster virus.
    Edmunds WJ, Brisson M.
    J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence.
    Oxman MN.
    J Am Osteopath Assoc; 2009 Jun; 109(6 Suppl 2):S13-7. PubMed ID: 19553630
    [Abstract] [Full Text] [Related]

  • 10. Simian varicella: a model for human varicella-zoster virus infections.
    Gray WL.
    Rev Med Virol; 2004 Jun; 14(6):363-81. PubMed ID: 15386593
    [Abstract] [Full Text] [Related]

  • 11. Key issues in varicella-zoster virus latency.
    Kennedy PG.
    J Neurovirol; 2002 Dec; 8 Suppl 2():80-4. PubMed ID: 12491156
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Varicella zoster virus infection involving the maxillary branch of the trigeminal nerve].
    Warman M, Halperin D.
    Harefuah; 2007 Feb; 146(2):89-91, 167. PubMed ID: 17352273
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Natural history of varicella zoster virus.
    Tyring SK.
    Semin Dermatol; 1992 Sep; 11(3):211-7. PubMed ID: 1390036
    [Abstract] [Full Text] [Related]

  • 17. Molecular and therapeutic aspects of varicella-zoster virus infection.
    Quinlivan M, Breuer J.
    Expert Rev Mol Med; 2005 Aug 10; 7(15):1-24. PubMed ID: 16098235
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [A mini epidemic of varicella zoster virus reinfection at a department of hematology].
    Junker K, Avnstorp C, Nielsen CM, Hansen NE.
    Ugeskr Laeger; 1989 Apr 10; 151(15):935-7. PubMed ID: 2540583
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.